Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis

Arthritis & Rheumatism

Volumn 38, Issue 10, 1995, Pages 1466-1474

  Heide, Agnes Van Der ^a   Remme, Carol Ann ^b   Hofman, Dirk M ^b   Jacobs, JOHANNES W G ^b   Bijlsma, JOHANNES W J ^b  

^a Stichting Reumaonderzoek Utrecht [Sru] ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; SYNOVITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RHEUMATOID FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0028807079     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780381013     Document Type: Article

References (47)

1. Relationship between radiologic and clinical findings in rheumatoid arthritis
2. Radiological assessment of outcome in rheumatoid arthritis
3. Methods of scoring the progression of radiologic changes in rheumatoid arthritis
4. Setting the scene and posing the questions
5. Use of the radiograph to measure the course of rheumatoid arthritis: the gold standard versus fool's gold
6. Reproducibility of multiple‐observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis
7. Radiological grading of rheumatoid arthritis
8. Observer variation in quantitative assessment of rheumatoid arthritis. II. A simplified scoring system
9. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
10. The impact of endpoint measures in rheumatoid arthritis clinical trials
11. Clinical, laboratory and radiographic features in early rheumatoid arthritis
12. Radiographic changes in early rheumatoid disease
13. Assessment of radiological changes in the hands and feet in rheumatoid arthritis: their correlation with prognosis
14. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease
15. Early rheumatoid arthritis: onset, course, and outcome over 2 years
16. Biannual radiographic assessments of hands and feet in a three‐year prospective followup of patients with early rheumatoid arthritis
17. Methods of x‐ray assessment in rheumatoid arthritis: a reevaluation
18. Lack of correlation between the Steinbrocker staging of hand radiographs and the functional health status of individuals with rheumatoid arthritis
19. The relation of radiographic changes to serum acute‐phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis
20. Clinical and laboratory assessment of outcome in rheumatoid arthritis
21. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis
22. Which traditional measures should be used in rheumatoid arthritis clinical trials
23. Radiographic progression of rheumatoid arthritis related to some clinical and laboratory parameters
24. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C‐reactive protein and erythrocyte sedimentation rate
25. The acute‐phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease
26. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologic damage, physical disability, joint counts, and acute phase reactants
27. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis
28. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis
29. Prognosis in rheumatoid arthritis: a longitudinal study of newly diagnosed younger adult patients
30. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow‐up study of 147 patients
31. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis
32. Factors predicting outcome of rheumatoid arthritis: results of a followup study
33. Rheumatoid arthritis: relation of serum C‐reactive protein and erythrocyte sedimentation rates to radiographic changes
34. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D‐penicillamine therapy
35. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11‐year follow up
36. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
37. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis
38. Measurement of patient outcome in arthritis
39. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis
40. Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis
41. Articular indices for joint inflammation with rheumatoid arthritis: correlation with the acute‐phase response
42. Evaluation of the Thompson articular index
43. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis
44. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis
45. Intramuscular depot of methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24‐week randomized controlled trial
46. Long term progression of joint damage in rheumatoid arthritis
47. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years